StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Alvotech r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $184.19M, up 7.5% from the year before. The highest annual figure on record is $210.83M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$184.19M+7.5%
FY2024Dec 31, 2024$171.31M-18.7%
FY2023Dec 31, 2023$210.83M+16.7%
FY2022Dec 31, 2022$180.62M-5.4%
FY2021Dec 31, 2021$191.01M+29.0%
FY2020Dec 31, 2020$148.07M–

More Alvotech figures

See a number that looks wrong?